Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Data Integrity
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Newsmakers Interviews
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
A Potential “Marriage”
Initiator companies and generics/CMOs working together.Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
-
Injectables Firms Expand Capacity
CDMOs see steriles demand grow.S. Harachand, Contributing Editor 11.17.20
-
When Politics and Science Collide
COVID-19 illustrates why science should always be a principal informer of politics to make better and smarter decisions.Ben Locwin, Contributing Editor 11.17.20
-
The Importance of Hypothesis Testing During Investigations
Why it is critical to have controls in place during out-of-specification investigations to provide quality assurance.Paul Mason, PhD, Lachman Consultants 11.17.20
-
The Art and Science of Recruitment
Chapter Three: Landing the Best Candidate.David G. Jensen, Contributing Editor 11.17.20
-
Pfizer’s COVID-19 Vax Breakthrough
mRNA-based vaccine candidate found to have an efficacy rate above 90% in preventing COVID-19.Tim Wright, Editor 11.17.20
-
Outsourcing Accelerates
The COVID-19 pandemic has boosted growth across all facets of the contract services sector.Tim Wright, Editor 10.14.20
-
The Pandemic’s Become an Insurmountable Opportunity
Every Cloud has a Silver Lining(?)Emil W. Ciurczak, Contributing Editor 10.14.20
-
The Changing Approach to Design: Five Ways to Achieve Warp Speed
Revisiting facility design and construction based on today’s biopharmaceutical industry needs.Jarrod Wrampe, Contributing Editor 10.14.20
-
The Art and Science of Recruitment
Chapter Two: Building Word-of-Mouth Via Networking.David G. Jensen, Contributing Editor 10.14.20
-
Biologics, Proteins, Vaccines | Biosimilars | R&D
The Global Biotech Boom
How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.Davide Garrisi, PPD Biotech 09.09.20
-
Supply Chain Woes Vex Markets
Indian players ramp up chloroquine productionS. Harachand, Contributing Editor 09.09.20
-
Biologics, Proteins, Vaccines | Regulatory Affairs
Ensuring Manufacturing Continuity for Essential Medicines
Applying the principles of Quality Risk Management to get medicines to market faster.John Darby, M.Sc., Senior Director, Lachman Consultant Services, Inc. 09.09.20
-
Biologics, Proteins, Vaccines
![It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]](https://dev.rodpub.com/images/218/898_thumb.jpg)
It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]
Race for the vaccines is heating up.Ben Locwin, Contributing Editor 09.09.20
-
The Art and Science of Recruitment
Chapter One: Define your need. Craft your message.David G. Jensen, Contributing Editor 09.09.20
-
The Ongoing Impact of COVID-19
Contract Pharma’s Conference Web Series kicks off Sept. 23 and features COVID-19-themed sessions.Tim Wright, Editor 09.09.20
-
The “Three Cs” of C(D)MO Selection
Plus, what does it take for contract organizations to fall in the “Goldilocks” zone for pharmaceutical companies?Valdas Jurkauskas, Ph.D., Akebia Therapeutics 07.15.20
-
Biologics, Proteins, Vaccines
Pharma’s Fight Against the Coronavirus Pandemic
A look at the pharma industry’s concerted effort to develop vaccines against the SARS-CoV-2 virus and therapeutics to treat COVID-19.Keith O. Webber, Lachman Consultant Services, Inc. 07.15.20
-
Top 25 Pharma & Biopharma
Combined pharma sales for the 2020 Top Companies came close to $650 billion.Tim Wright, Editor 07.15.20
